YbaƱez, Conchita N.
HRN: 22-17-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
CLINDAMYCIN 300MG (CAP)
11/06/2022
11/12/2022
PO
300 Mg
Q6
Wound Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes